KBC Securities - ArGEN-X SE (ARGX) ... Morning Notes : ARGX BB, DEME BB

Report

KBC Securities

Guy Sips ...

Hilde Van Boxstael
Thomas Vranken
Wim Lewi

Morning Notes : ARGX BB, DEME BB

: ARGX BB, DEME BB

20/06/2024 1 EN

Underlyings

ArGEN-X SE

Argenx N.V. is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Utilizing its suite of differentiated technologies, Co. is focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need.

See profile

NL0010832176 Euronext Brussels Netherlands

DEME GROUP NV

See profile

BE0974413453 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Guy Sips

Hilde Van Boxstael

Thomas Vranken

Wim Lewi

Other Reports on these Companies

KBC Securities

Morning Notes : ARGX BB, BAR BB, DIE BB, ALFEN NA

: ARGX BB, BAR BB, DIE BB, ALFEN NA

June 26, 2024 June 26, 2024 1 EN

GlobeNewsWire

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of functional improvements with VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc), which is FDA approved for use in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) June 25, 2024 – 4:30pm EDT Amsterdam, the Netherlands – argenx SE (Euro...

June 25, 2024 June 25, 2024 1 EN

Oddo BHF

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 06/24/2024

Dutch real estate companies showed signs of cautious optimism at the recent Provada conference, with logistics and retail favoured. Healthcare shows some positive signs, with limited devaluations. The Dutch government's potential reduction of the Real Estate Transfer Tax and new REIT regime could benefit listed real estate companies active in the country. - ...

June 24, 2024 June 24, 2024 1 EN

Morning Notes : OPTI BB, NXFIL NA

: OPTI BB, NXFIL NA

June 28, 2024 June 28, 2024 1 EN

Wim Lewi

Wim Lewi

Xior Upgrade to BUY after CiK and new cornerstone investor

This morning, Xior announced an Contribution in Kind (CiK) agreement to acquire two PBSA assets in Lisbon and Kraków. Together for a total of 670 units/1,053 beds and an average gross investment yield of 8.41%. These acquisitions are realised entirely by CiK against the issue of new shares at an issue price of EUR 29.02. The total contribution value is approx. 80 MEUR, which strengthens Xior's equity and reduces the LTV by 1,1%. We like this CiK deal as it combines growth with LTV reduction. The relative high yield compensates the discount to NTA of the newly issued shares. The placement of th...

June 27, 2024 June 27, 2024 1 EN

Hilde Van Boxstael ... (+4)

Hilde Van Boxstael
Michiel Declercq
Thomas Couvreur
Wim Lewi

Morning Notes : ASRNL NA, PROX BB, XIOR BB

: ASRNL NA, PROX BB, XIOR BB

June 27, 2024 June 27, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : ARGX BB, DEME BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : ARGX BB, BAR BB, DIE BB, ALFEN NA

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 06/24/2024

Morning Notes : OPTI BB, NXFIL NA

Xior Upgrade to BUY after CiK and new cornerstone investor

Morning Notes : ASRNL NA, PROX BB, XIOR BB

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe